The End of the Longest Government Shutdown

by | Feb 10, 2019 | FDA, Medical Devices, Quality Systems, Regulatory, Shutdown

The government has temporarily “re-opened” until Feb 15th after the longest government shutdown in US history that lasted for 35 days.

Here’s what’s going to happen:

Some FDA officials carried out inspections and other critical activities without being paid to continue to respond to threats to public health. Around 800,000 federal workers have been promised a back pay.1

The resumed activities amid the shutdown were funded by the carryover user fees of certain review applications. These applications were experiencing delays in their review and now pose as a backlog since the industry will now start submitting new applications after a long wait.

FDA has started accepting new pre-market review applications but of course, the timelines of the review will suffer because of the backlog.

The shutdown has already caused lasting damage in other agencies as well. As for the FDA, the agency will still face a backlog of applications and other regulatory activities that will continue for the near future.2 Medical device manufacturers who plan on submitting a 510(k) or a PMA anytime soon will face delayed clearances for their devices.

We are closely monitoring the activities in D.C. and will keep you updated on any changes that will impact the Medical Device industry.

If you need help in preparing your 510(k) or PMA, please call us at 248-987-4497 or email us at info@emmainternational.com.


1Vox (Jan 2019) The government is reopened (for now). But the recovery process may take a while. Retrieved on 02/07/2019 from https://www.vox.com/2019/1/26/18198630/government-shutdown-recovery

2Health Law Advisor (Jan 2019) Not Business as Usual: The Government Shutdown’s Impact at FDA. Retrieved on 02/07/2019 from https://www.healthlawadvisor.com/2019/01/22/not-business-as-usual-the-government-shutdowns-impact-at-fda/

Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.
Is your product a medical device?

Is your product a medical device?

Many marketed products are classified as medical devices and you would not even know it. Medical devices range from latex gloves and tongue depressors to respirators and heart valves. To determine if the product is considered a medical device by the Food and Drug Administration (FDA) you will need to analyze if your product meets the definition of a medical device per the Food, Drug, and Cosmetic Act1.

Ready to learn more about working with us?

Pin It on Pinterest

Share This